GeneFluidics was incorporated in 2000 to develop a fast, accurate, and simple testing system for improving worldwide health. By integrating novel bionano and microfluidic technologies, the company’s revolutionary platform enables complex tests that are normally performed only by skilled technicians in a laboratory to be performed by anyone, anywhere.

Originally conceived as part of a biodefense program, the platform integrates nanotechnology-enabled analyte detection with microfluidic-based automated sample preparation for rapid and accurate ‘plug and play’ use. For system operation, the user simply introduces a raw sample such as whole blood, urine, saliva, or water to a disposable cartridge, inserts this cartridge into a reader instrument, pushes a button, and waits 10-20 minutes for the results.